2nd Quarter - Report

AVENUE SOLUTIONS for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; H.R. 1672, Maintaining Investments in New Innovation Act; Biosimilars Access and Affordability Act; H.R. 2484, Seniors Access to Critical Medications Act; H.R. 946/S. 1862, ORPHAN Cures Act; Issues related to PBM reform; Issues related to Most Favored Nation (MFN) drug pricing proposal

LobbyistCovered position, as disclosed
MATTHEW FUENTES —
JORDAN A LACROSSE —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1672 (119th), H.R. 946 (119th), S. 475 (119th), H.R. 1227 (119th), S. 1862 (119th), H.R. 2484 (119th)

Health Issues HCR

Monitor issues related to 340b; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)

LobbyistCovered position, as disclosed
MATTHEW FUENTES —
JORDAN A LACROSSE —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 14 (119th), H.R. 1 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.